Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans L Tillmann

Showing results (31-40 of 127) with videos related to

Pageof 13
Sort By:
Hepatology (Baltimore, Md.)|August 14, 2009
Does hepatitis B surface antigen kinetics, including both decline and reaching a threshold, improve prediction of response?Johannes Wiegand, Keyur Patel, Hans L Tillmann
Gastroenterology|May 20, 2008
GBV-C in HIV-HCV coinfection, low liver-related mortality but high overall mortalityHans L Tillmann, Keyur Patel, John G McHutchison
Molecular Diagnosis & Therapy|September 12, 2013
Individualized therapy for hepatitis C infection: focus on the interleukin-28B polymorphism in directing therapyTzu-Hao Lee, Hans L Tillmann, Keyur Patel
The Journal of Infectious Diseases|January 25, 2018
A Downside to Hepatitis C Virus Cure? Vigilance Is Needed Regarding Hepatitis B Virus Reactivation, Organ Rejection, or Hepatocellular Carcinoma ProgressionSirish Sanaka, George R Kasarala, Hans L Tillmann
Current Gastroenterology Reports|January 27, 2009
Role of growth factors and thrombopoietic agents in the treatment of chronic hepatitis CHans L Tillmann, Keyur Patel, John G McHutchison
Liver International : Official Journal of the International Association for the Study of the Liver|November 22, 2011
Management of severe acute to fulminant hepatitis B: to treat or not to treat or when to treat?Hans L Tillmann, Kalliopi Zachou, George N Dalekos
Acupuncture in Medicine : Journal of the British Medical Acupuncture Society|July 7, 2020
Opioid weaning made possible by pain control with Battlefield AcupunctureHans L Tillmann, Walter R Nelson, Michael Freedman
Molecular Diagnosis & Therapy|December 4, 2013
A rationalized approach to the treatment of patients infected with hepatitis BNatravis R Cox, Keyur Patel, Hans L Tillmann
Digestive Diseases and Sciences|October 27, 2023
Size Matters! Anti-HBs Titer and HBV Reactivation During Anti-TNF TherapyShiva Poola, MaryKate Kratzer, Kerry Sewell, et al.
Journal of Viral Hepatitis|October 13, 2020
Hepatitis B surface antibody titres and hepatitis B reactivation with direct-acting antiviral therapy for hepatitis CShiva Poola, Sirish Sanaka, Kerry Sewell, et al.
Pageof 13

Showing results (31-40 of 127) with videos related to

Sort By:
Pageof 13
Hepatology (Baltimore, Md.)|August 14, 2009
Does hepatitis B surface antigen kinetics, including both decline and reaching a threshold, improve prediction of response?Johannes Wiegand, Keyur Patel, Hans L Tillmann
Gastroenterology|May 20, 2008
GBV-C in HIV-HCV coinfection, low liver-related mortality but high overall mortalityHans L Tillmann, Keyur Patel, John G McHutchison
Molecular Diagnosis & Therapy|September 12, 2013
Individualized therapy for hepatitis C infection: focus on the interleukin-28B polymorphism in directing therapyTzu-Hao Lee, Hans L Tillmann, Keyur Patel
The Journal of Infectious Diseases|January 25, 2018
A Downside to Hepatitis C Virus Cure? Vigilance Is Needed Regarding Hepatitis B Virus Reactivation, Organ Rejection, or Hepatocellular Carcinoma ProgressionSirish Sanaka, George R Kasarala, Hans L Tillmann
Current Gastroenterology Reports|January 27, 2009
Role of growth factors and thrombopoietic agents in the treatment of chronic hepatitis CHans L Tillmann, Keyur Patel, John G McHutchison
Liver International : Official Journal of the International Association for the Study of the Liver|November 22, 2011
Management of severe acute to fulminant hepatitis B: to treat or not to treat or when to treat?Hans L Tillmann, Kalliopi Zachou, George N Dalekos
Acupuncture in Medicine : Journal of the British Medical Acupuncture Society|July 7, 2020
Opioid weaning made possible by pain control with Battlefield AcupunctureHans L Tillmann, Walter R Nelson, Michael Freedman
Molecular Diagnosis & Therapy|December 4, 2013
A rationalized approach to the treatment of patients infected with hepatitis BNatravis R Cox, Keyur Patel, Hans L Tillmann
Digestive Diseases and Sciences|October 27, 2023
Size Matters! Anti-HBs Titer and HBV Reactivation During Anti-TNF TherapyShiva Poola, MaryKate Kratzer, Kerry Sewell, et al.
Journal of Viral Hepatitis|October 13, 2020
Hepatitis B surface antibody titres and hepatitis B reactivation with direct-acting antiviral therapy for hepatitis CShiva Poola, Sirish Sanaka, Kerry Sewell, et al.
Pageof 13